KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares RepurchasedShort-Term Debt repayments
Ratios

Elevance Health (ELV) Receivables - Other (2016 - 2025)

Elevance Health (ELV) has disclosed Receivables - Other for 17 consecutive years, with $7.7 billion as the latest value for Q3 2025.

  • On a quarterly basis, Receivables - Other rose 27.04% to $7.7 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $7.7 billion, a 27.04% increase, with the full-year FY2024 number at $6.0 billion, up 11.3% from a year prior.
  • Receivables - Other was $7.7 billion for Q3 2025 at Elevance Health, up from $7.2 billion in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $7.7 billion in Q3 2025 to a low of $1.5 billion in Q4 2021.
  • A 5-year average of $4.8 billion and a median of $5.1 billion in 2024 define the central range for Receivables - Other.
  • Peak YoY movement for Receivables - Other: crashed 47.0% in 2021, then skyrocketed 186.53% in 2022.
  • Elevance Health's Receivables - Other stood at $1.5 billion in 2021, then surged by 186.53% to $4.3 billion in 2022, then rose by 25.76% to $5.4 billion in 2023, then grew by 11.3% to $6.0 billion in 2024, then increased by 27.86% to $7.7 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Receivables - Other are $7.7 billion (Q3 2025), $7.2 billion (Q2 2025), and $6.6 billion (Q1 2025).